COCH
Envoy Medical Inc.
NASDAQ: COCH · HEALTHCARE · MEDICAL DEVICES
$0.68
+0.47% today
Updated 2026-04-30
Market cap
$51.86M
P/E ratio
—
P/S ratio
215.20x
EPS (TTM)
$-1.23
Dividend yield
—
52W range
$0 – $2
Volume
0.3M
Envoy Medical Inc. (COCH) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $310000.00 | $237000.00 | $316000.00 | $225000.00 | $241000.00 |
| Revenue growth (YoY) | — | — | -23.5% | +33.3% | -28.8% | +7.1% |
| Cost of revenue | — | $769000.00 | $498000.00 | $789000.00 | $742000.00 | $874000.00 |
| Gross profit | — | $-459000.00 | $-261000.00 | $-473000.00 | $-517000.00 | $-633000.00 |
| Gross margin | — | -148.1% | -110.1% | -149.7% | -229.8% | -262.7% |
| R&D | — | $3.94M | $4.97M | $8.96M | $10.18M | $12.49M |
| SG&A | — | $2.47M | $2.58M | $7.26M | $6.83M | $7.93M |
| Operating income | $-701.00 | $-6.87M | $-8.71M | $-18.36M | $-19.26M | $-22.27M |
| Operating margin | — | -2216.5% | -3673.4% | -5809.8% | -8558.2% | -9240.7% |
| EBITDA | $-701.00 | $-6.80M | $-8.63M | $-29.79M | $-19.81M | $-21.97M |
| EBITDA margin | — | -2193.5% | -3641.8% | -9426.9% | -8802.7% | -9115.4% |
| EBIT | $-206997.00 | $-6.87M | $-8.71M | $-29.92M | $-19.98M | $-22.27M |
| Interest expense | — | — | — | $0.00 | $816000.00 | $1.59M |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-701.00 | $-8.68M | $-15.92M | $-29.92M | $-20.80M | $-23.76M |
| Net income growth (YoY) | — | -1237417.8% | -83.6% | -87.9% | +30.5% | -14.2% |
| Profit margin | — | -2798.4% | -6718.6% | -9469.0% | -9242.2% | -9857.3% |